IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) patients commonly present with advanced stage disease and demonstrate resistance to therapy, with response rates below 40%. Understanding the molecular mechanisms of resistance is crucial for improvement of clinical outcomes. IGFBP2 is a member of the IGFBP family of...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Amy L., Lin, Lin, Nancarrow, Derek J., Wang, Zhuwen, Ferrer-Torres, Daysha, Thomas, Dafydd G., Orringer, Mark B., Lin, Jules, Reddy, Rishindra M., Beer, David G., Chang, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694874/
https://www.ncbi.nlm.nih.gov/pubmed/26317790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694874/
https://www.ncbi.nlm.nih.gov/pubmed/26317790

Ejemplares similares